Amifostine Protects Small Bowel Against Radiation-induced Apopitosis by Reducing Caspase-3
Abstract
Objective: The aim of the study was to investigate the protective effect of amifostine against radiotherapy-induced small bowel injury.
Materials and Methods: Forty rats were divided equally into four groups as control, irradiation (IR), IR + Amifostine, IR+N-acetyl cysteine (NAC) groups. Caspase-3 expression, villus lengths, and microscopic tissue injury were evaluated histopathologically. Superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), myeloperoxidase (MPO) and malondialdehyde (MDA) were measured biochemically in jejunum tissue. Pre- and post-radiation weights of the rats were recorded.
Results: Caspase-3 was at the highest level in the IR group, at the lowest level in the control and weak in the Amifostine+IR group. The lowest microscopic score was determined in the IR group and the difference between the groups was statistically significant. CAT decreases after IR. However, Amifostine and NAC prevented radiation-induced catalase decline. In Amifostine+IR group, the villus length was significantly longer than that of the IR group. Amifostine was observed to protect against weight loss.
Conclusion: The results obtained from this study demonstrate that the administration of Amifostine can substantially reduce apopitosis and support the repair of the structure and function of intestinal tissues which have been damaged by exposure to radiation. These results also suggest that it may be a promising therapeutic agent.
Keywords
References
- 1 Kaliberov SA, and Buchsbaum D, 'Cancer Treatment with Gene Therapy and Radiation Therapy', in Advances in Cancer Research. Curiel DT, Fisher PB (eds.) (Elsevier, 2012), pp. 221-63.
- 2 Shinomiya N, 'New Concepts in Radiation‐Induced Apoptosis:‘Premitotic Apoptosis’ and ‘Postmitotic Apoptosis’', J Cell Mol Med., 5 (2001), 240-53.
- 3 Gracy RW, Talent JM, Kong Y, and Conrad CC, 'Reactive Oxygen Species: The Unavoidable Environmental Insult?', Mutat Res. 428 (1999), 17-22.
- 4 Pulli B, Ali M, Forghani R, Schob S, Hsieh KL, Wojtkiewicz G, Linnoila JJ, Chen JW., et al., 'Measuring Myeloperoxidase Activity in Biological Samples', PloS one, 8 (2013), e67976.
- 5 Pandey BN, and Mishra KP, 'Fluorescence and Esr Studies on Membrane Oxidative Damage by Gamma Radiation', Appl Magn Reson., 18 (2000), 483-92.
- 6 Cox JD, Byhardt RW, Wilson JF, Haas JS, Komaki R, Olson LE, 'Complications of Radiation Therapy and Factors in Their Prevention', World J Surg, 10 (1986), 171-88.
- 7 Weiss JF, Landauer MR., 'History and Development of Radiation-Protective Agents', Int J Radiat Biol., 85 (2009), 539-73.
- 8 Irwin Fridovich, 'Superoxide Dismutases', Adv Enzymol Relat Areas Mol Biol, 58 (1986), 61-97.
Details
Primary Language
English
Subjects
Health Care Administration
Journal Section
Research Article
Publication Date
September 30, 2018
Submission Date
July 27, 2018
Acceptance Date
September 4, 2018
Published in Issue
Year 2018 Volume: 8 Number: 3